Free shipping over €250 · Tracked, discreet delivery in Europe
UU library
Every peptide, mapped to the body.
160 compounds, from approved medicines to early research molecules. Each one filed by the system research looks at, with its regulatory status and the strength of the evidence behind it.
- Compounds
- 160
- Research summaries
- 39
- At UU
- 56
- Approved medicine71
Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.
- In clinical trials19
In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.
- Research compound53
Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.
- Cosmetic ingredient17
Used as a topical cosmetic ingredient. Cosmetic use is not a medicinal approval, and most evidence comes from manufacturer and small panel studies.
Reviewed October 2026
In the UU catalog
Researched, batch-tested, ready to ship.
Compounds UU carries that have a full research summary in the library.
32 compounds · Hormones & growth
Hormones & growth32
Growth hormone secretagogues, IGF analogues and the pituitary and endocrine peptides.
- ApprovedAt UU
Tesamorelin
Egrifta
GHRH analogue
A growth hormone-releasing hormone analogue approved to reduce excess abdominal fat in HIV-associated lipodystrophy.
Human trialsShop - ResearchAt UU
CJC-1295 with DAC
Long-acting GHRH analogue
A GHRH analogue that binds albumin to stay in circulation for days. Studied in early human trials for sustained IGF-1 elevation.
Early human dataShop - ResearchAt UU
Ipamorelin
Ghrelin receptor agonist
A selective growth hormone secretagogue pentapeptide. Studied for growth hormone release with little effect on cortisol or prolactin.
Early human dataShop - ResearchAt UU
Kisspeptin-10
Kisspeptin receptor agonist
The shortest active fragment of kisspeptin, the upstream signal for GnRH. Studied in human physiology research on reproductive hormones.
Early human dataShop - ResearchAt UU
Sermorelin
GRF 1-29
GHRH analogue
The first 29 residues of growth hormone-releasing hormone. Once approved in the US, it was withdrawn from the market in 2008.
Early human dataShop - ResearchAt UU
CJC-1295 without DAC
Modified GRF 1-29 · Mod GRF
GHRH analogue
A stabilised version of the first 29 residues of GHRH. Studied for short pulses of growth hormone release.
Mixed evidenceShop - Approved
Corticotropin
ACTH · Acthar
Pituitary hormone
The 39-residue pituitary hormone that drives cortisol release. Approved for infantile spasms and several inflammatory conditions.
Summary pending - Approved
Cosyntropin
Tetracosactide · Synacthen
ACTH(1-24)
The first 24 residues of ACTH. Approved as a diagnostic test of adrenal function.
Summary pending - Approved
Desmopressin
DDAVP
Vasopressin analogue
A vasopressin analogue that acts on the kidney. Approved for central diabetes insipidus, night-time urination and some bleeding disorders.
Summary pending - Approved
Etelcalcetide
Parsabiv
Calcimimetic
A peptide that activates the calcium-sensing receptor. Approved for secondary hyperparathyroidism on haemodialysis.
Summary pending - Approved
Gonadorelin
GnRH · Factrel
GnRH
Synthetic gonadotropin-releasing hormone. Approved as a diagnostic agent for pituitary function.
Summary pending - Approved
Human chorionic gonadotropin
hCG · Pregnyl
Glycoprotein hormone
The pregnancy hormone, a glycoprotein that acts at LH receptors. Approved to trigger ovulation and for some forms of hypogonadism.
Summary pending - Research
Humanin
Mitochondrial-derived peptide
A 24-residue peptide encoded in mitochondrial DNA. Studied in cell and animal models of ageing and neuroprotection.
Summary pending - Research
IGF-1 DES
DES(1-3) IGF-I
IGF-1 variant
A naturally occurring truncated IGF-1 with weak binding-protein affinity. Studied in cell and animal research.
Summary pending - Approved
Insulin analogues
Glargine · Lispro
Insulin
Engineered forms of the 51-residue pancreatic hormone, with faster or longer action. Approved for diabetes.
Summary pending - Approved
Lanreotide
Somatuline
Somatostatin analogue
A long-acting somatostatin analogue approved for acromegaly and neuroendocrine tumours.
Summary pending - Approved
Leuprolide
Leuprorelin · Lupron
GnRH agonist
A GnRH agonist approved for prostate cancer, endometriosis and central precocious puberty.
Summary pending - Approved
Macimorelin
Macrilen
Oral ghrelin receptor agonist
An oral peptidomimetic approved as a diagnostic test for adult growth hormone deficiency.
Summary pending - Approved
Mecasermin
Increlex
Recombinant IGF-1
Recombinant human IGF-1 approved for severe primary IGF-1 deficiency in children.
Summary pending - Research
MK-677
Ibutamoren
Oral ghrelin receptor agonist
An oral small molecule that mimics ghrelin. Studied in trials for growth hormone and IGF-1 levels, never approved.
Summary pending - Approved
Octreotide
Sandostatin
Somatostatin analogue
A somatostatin analogue approved for acromegaly and symptoms of neuroendocrine tumours.
Summary pending - Approved
Palopegteriparatide
Yorvipath
Long-acting PTH(1-34) prodrug
A prodrug that releases PTH(1-34) steadily. Approved for hypoparathyroidism in adults.
Summary pending - Approved
Pasireotide
Signifor
Somatostatin analogue
A multi-receptor somatostatin analogue approved for Cushing's disease and acromegaly.
Summary pending - Approved
Pegvisomant
Somavert
Growth hormone receptor antagonist
A modified growth hormone that blocks its own receptor. Approved for acromegaly.
Summary pending - Approved
Somapacitan
Sogroya
Long-acting growth hormone
A weekly growth hormone analogue approved for growth hormone deficiency.
Summary pending - Approved
Somatropin
Recombinant human growth hormone
Growth hormone
Recombinant human growth hormone, a 191-residue protein. Approved for growth hormone deficiency and several growth disorders.
Summary pending - Approved
Teriparatide
Forteo · Forsteo
PTH(1-34)
The first 34 residues of parathyroid hormone. Approved for osteoporosis at high risk of fracture.
Summary pending - Approved
Vasopressin
Vasostrict
Pituitary hormone
The nine-residue antidiuretic hormone. Approved to raise blood pressure in vasodilatory shock.
Summary pending
The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.